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Background
Human herpesvirus type-7 (HHV-7) is a recently
described herpesvirus, and neuroinvasion has been rarely
reported. We describe recurrent encephalitis associated
with HHV-7 in an immunocompetent host, who was suc-
cessfully treated with foscarnet.
Case report
A 32-year-old man was transferred to our hospital from a
local hospital because of a sudden onset of decreased
mental status and intermittent abnormal behavior. He
had been previously diagnosed with HSV-1 encephalitis
and treated with acyclovir for 20 days; after two months,
altered mental status and abnormal behavior occurred.
Brain magnetic resonance imaging (MRI) on admission
disclosed high-signal lesions involving the bilateral tem-
poral lobe on T2 weighted imaging. We examined a vari-
ety of viral DNA in cerebrospinal fluid and serum by
nested polymerase chain reaction.
Results
HHV-7 DNA was detected in both cerebrospinal fluid and
serum, suggesting neuroinvasion by HHV-7. No other
viral DNA was identified. After intravenous treatment
with foscarnet sodium 2000 mg every eight hours for two
weeks, the patient was significantly recovered except for a
mild memory deficit. Follow-up brain MRI showed that
the lesion had almost disappeared.
Conclusion
HHV-7 may cause meningoencephalitis in immunocom-
petent adults, and should be investigated as possible eti-
ology in the treatment of resistant encephalitis patients.
This case indicates that HHV-7 meningoencephalitis can
be effectively eradicated by foscarnet treatment.
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